US FDA adds 33 new entries to medtech standards list
This article was originally published in SRA
The US Food and Drug Administration has announced several changes to the list of medical device standards that the agency recognizes for use in pre-market reviews, including the addition of 33 new entries1.
You may also be interested in...
Five new drugs have been recommended for EU approval at the latest meeting of European Medicines Agency’s drug evaluation committee.
The European Commission has set aside, for now, concerns expressed by member states regarding the scope of medicines subjected to additional monitoring requirements.
A new work sharing pilot has been launched to evaluate jointly generic drugs intended for launch in Singapore and Malaysia.